Protalix BioTherapeutics, Inc. (AMEX: PLX), announced that Health Canada has granted regulatory approval to ELELYSO (taliglucerase alfa for injection) for ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE